Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity

por Baburajeev, C. P., Mohan, Chakrabhavi Dhananjaya, Rangappa, Shobith, Mason, Daniel J., Fuchs, Julian E., Bender, Andreas, Barash, Uri, Vlodavsky, Israel, Basappa, Rangappa, Kanchugarakoppal S.
Publicado 2017

Novel Adamantanyl-Based Thiadiazolyl Pyrazoles Targeting EGFR in Triple-Negative Breast Cancer

por Sebastian, Anusha, Pandey, Vijay, Mohan, Chakrabhavi Dhananjaya, Chia, Yi Ting, Rangappa, Shobith, Mathai, Jessin, Baburajeev, C. P., Paricharak, Shardul, Mervin, Lewis H., Bulusu, Krishna C., Fuchs, Julian E., Bender, Andreas, Yamada, Shuhei, Basappa, Lobie, Peter E., Rangappa, Kanchugarakoppal S.
Publicado 2016

Development of Novel Triazolo-Thiadiazoles from Heterogeneous “Green” Catalysis as Protein Tyrosine Phosphatase 1B Inhibitors

por Baburajeev, C. P., Dhananjaya Mohan, Chakrabhavi, Ananda, Hanumappa, Rangappa, Shobith, Fuchs, Julian E., Jagadish, Swamy, Sivaraman Siveen, Kodappully, Chinnathambi, Arunachalam, Ali Alharbi, Sulaiman, Zayed, M. E., Zhang, Jingwen, Li, Feng, Sethi, Gautam, Girish, Kesturu S., Bender, Andreas, Basappa, Rangappa, Kanchugarakoppal S.
Publicado 2015